June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Long-term results after Ahmed glaucoma valve implantation for different types of glaucoma
Author Affiliations & Notes
  • Olga Furashova
    Ophthalmology, University Hospital, Dresden, Germany
  • Karin Pillunat
    Ophthalmology, University Hospital, Dresden, Germany
  • Eberhard Spoerl
    Ophthalmology, University Hospital, Dresden, Germany
  • Lutz Pillunat
    Ophthalmology, University Hospital, Dresden, Germany
  • Footnotes
    Commercial Relationships Olga Furashova, None; Karin Pillunat, None; Eberhard Spoerl, None; Lutz Pillunat, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4783. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Olga Furashova, Karin Pillunat, Eberhard Spoerl, Lutz Pillunat; Long-term results after Ahmed glaucoma valve implantation for different types of glaucoma. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4783.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To present long-term outcomes of Ahmed glaucoma valve implantation in patients with different types of glaucoma.

Methods: Retrospective chart review of 214 patients (214 eyes) with different types of glaucoma, who underwent Ahmed valve implantation (model FP7, New World Medical, Rancho Cucamonga, CA). Surgical success was defined as an IOP reduction of more than 20% and additionally between 5 and 21 mmHg at 1,2,3 and 4 years after surgery.

Results: Among the 214 eyes were 32.2% suffering from neovascular glaucoma (NVG), 28.5% suffering from primary open angle glaucoma (POAG), 10.7% suffering from congenital glaucoma, 7.9% suffering from uveitic glaucoma, 3.7% suffering from pseudoexfoliative glaucoma, 1.9% suffering from angle closure glaucoma and 23% suffering from other secondary types of glaucoma. Mean IOP preoperative was 38.6+-11.2 mmHg. After 1 year follow-up, the success rate was 92.3% (167 of 181 eyes) with mean IOP 14.7+-5.0 mmHg (p<0.001; t-test for paired samples); by 2 years, the success rate was 93.6% (147 of 157 eyes) with mean IOP 14.3+-4.7 mmHg (p<0.001; t-test for paired samples). At 3 and 4 years after implantation success rates were 95.2% (119 of 125 eyes) with mean IOP 14.0+-4.7 mmHg (p<0.001; t-test for paired samples) and 92.3% (84 of 91) with mean IOP 14.0+-4.6 mmHg (p<0.001; t-test for paired samples) respectively. At four years, the success rate in the POAG group was significantly higher than that in the NVG group (96% vs. 75%, p=0.04 by Chi2-test). Preoperative history of cyclocryocoagulation/cyclophotocoagulation was not a significant risk factor for surgical failure of Ahmed valve implantation (97% success rate in the group with previous cyclocryocoagulation/cyclophotocoagulation vs. 93% in the group without these; p=0.410 by Chi2-test).

Conclusions: Ahmed glaucoma valve implantation is a safe and successful procedure for decompensated glaucoma. Long - term success rates are depending on the type of glaucoma. A history of cyclocryocoagulation or cyclophotocoagulation seems not to be a risk factor for failure after Ahmed valve implantation.

Keywords: 568 intraocular pressure • 420 anterior chamber  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.